Page 15 - Visual Sciences News Today

 E-Mail IMAGE: Michael A. Kass, MD, (right) led the national Ocular Hypertension Treatment Study to determine whether lowering elevated eye pressure in patients might prevent vision loss from glaucoma. Kass and colleague... view more  Credit: Washington University School of Medicine More than 20 years after the launch of a landmark clinical trial, follow-up examinations and analyses found that not all patients with elevated eye pressure need pressure-lowering treatment to prevent visi...

Landmark study shows most patients with elevated pressure don’t go on to lose vision April 15, 2021 SHARE Michael A. Kass, MD, (right) led the national Ocular Hypertension Treatment Study to determine whether lowering elevated eye pressure in patients might prevent vision loss from glaucoma. Kass and colleague Mao O. Gordon, PhD, recently completed follow-up studies on patients 20 years after the start of the original study and found that not all patients with elevated eye pressure need...

Punch Newspapers Sections Lara Adejoro Vice-President, Ophthalmological Society of Nigeria and Consultant Ophthalmologist at The Eye Doctors Clinic, Dr. Abiola Oyeleye, says some glaucoma eye drops can ‘minimally increase’ the incidence of sexual dysfunction and impotence. He, however, added that the benefits of the eye drops far outweigh the consideration of not using them. Oyeleye spoke in reaction to a study published by the National Centre for Biotechnology Information on the correlatio...

SARS-CoV-2’s nonstructural proteins dysregulate immune responses, study finds The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease 2019 (COVID-19), is a novel pathogen that emerged in December 2019 in China. Since then, it has spread globally to over 191 countries and territories, infecting more than 96.82 million people and claiming over 2 million lives. As the virus continues to spread and new highly infectious variants emerge, unde...

Posted on 553 Aviceda Therapeutics, a late-stage, pre-clinical biotech company focused on developing the next generation of immuno-modulators by harnessing the power of glycobiology to manipulate the innate immune system and chronic, non-resolving inflammation, is announcing the composition of the Executive Team that will guide the company through ongoing development of breakthrough, first-in-class therapeutics and continued growth o...

Prevent Blindness Issues Call for Nominations for Jenny Pomeroy Award for Excellence in Vision and Public Health, and the Rising Visionary Award Share Article Prevent Blindness has issued the call for nominations for the “2021 Jenny Pomeroy Award for Excellence in Vision and Public Health,” and the second annual “Rising Visionary Award.” Prevent Blindness has issued the call for nominations for the “2021 Jenny Pomeroy Award for Excellence in Vision and Public Health,” and the secon...

Study: Specific class of drugs can be repurposed to treat genetic diseases Researchers at the University of Illinois Chicago have published a study showing a promising approach to using drug repurposing to treat genetic diseases. A team from the UIC Department of Ophthalmology and Visual Sciences published the article, "Gene dosage manipulation alleviates manifestations of hereditary PAX6 haploinsufficiency in mice" in the journal Science Translational Medicine. Nearly all the genes in human D...

Study in mice shows genes may be altered through drug repurposing Researchers at the University of Illinois Chicago have published a study showing a promising approach to using drug repurposing to treat genetic diseases. A team from the UIC Department of Ophthalmology and Visual Sciences published the article, "Gene dosage manipulation alleviates manifestations of hereditary PAX6 haploinsufficiency in mice" in the journal Science Translational Medicine. Nearly all the genes in human DNA have ...

Research to Prevent Blindness continues its support of ophthalmology research at UAB December 14, 2020 Written by: Leah Glenn Photography: University Relations/Steve WoodThe University of Alabama at BirminghamDepartment of Ophthalmology and Visual Sciences has received a $115,000 grant from Research to Prevent Blindness, to support research into the causes, treatment and prevention of blinding diseases. “The generous support from Research to Prevent Blindness to the UAB vision re...